Telehealth

A new initiative is tackling the fear and distrust that costs patients their health and the system trillions. Is 'cognitive safety' healthcare's next frontier?

RxSight will showcase its unique post-surgery adjustable lens at J.P. Morgan, facing investor questions on growth in a competitive ophthalmology market.

With patent cliffs looming and big bets on M&A, all eyes are on BMS to prove its growth strategy and high-stakes pipeline can deliver in 2026.

Following the sale of its legacy business, the newly-rebranded Accendra Health launches on the NYSE with a laser focus on the booming home healthcare market.

Riding a wave of record revenue and a favorable reimbursement outlook, iRhythm's upcoming JPM presentation is a key test for its 2026 growth strategy.

With a novel therapy from newborn heart cells, Secretome Therapeutics heads to J.P. Morgan to showcase its progress against intractable heart failure.

After retiring $1.4M in toxic debt, QHSLab has secured fresh equity to scale its AI-driven primary care platform, marking a pivotal turnaround.

With a new CEO and a booming market, mobile care provider instED is poised for major expansion. Here's what the move means for the future of healthcare.

A unique partnership brings accessible genetic testing to Boca Raton, using a community race to empower families with critical health knowledge.

Quebec pauses its controversial Bill 2 after a landmark deal with family doctors. The agreement replaces penalties with incentives, but what does it mean?

Charlesbank's strategic funding validates HBox’s 'clinic within a clinic' model, aiming to revolutionize care for high-risk chronic conditions.

Molecular Partners readies for a pivotal presentation at the J.P. Morgan conference, showcasing its next-gen DARPin therapeutics for hard-to-treat cancers.

New clinically aware AI agents offer empathetic, 24/7 patient support, aiming to reduce provider burnout and improve access to care for all.

A breakthrough clinical trial and a savvy financial move could net Fractyl Health $18M to advance its novel obesity treatment beyond the GLP-1 boom.

CMS's new ACCESS model spotlights virtual care, positioning firms like FlyteHealth to lead a tech-driven transformation in managing chronic illness.

As Spruce Biosciences preps its rare disease drug for FDA review, the addition of a commercial veteran signals a high-stakes shift from R&D to market.

A new nonprofit telehealth platform for men is launching, but its true innovation may lie in its ambitious blend of holistic care and community support.

OMRON's new global ECG strategy leverages AI and key acquisitions to tackle heart disease, aiming to eliminate adverse cardiovascular events.

Providence Care's new CEO is a former therapist. Can his clinical insight solve market challenges and deliver on a private equity growth plan?

An award-winning telecom platform reveals how AI-driven, unified journeys can transform customer experience. What can healthcare learn from this model?